Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
ELISA
Western Blot
3D Cell Culture
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
White Paper
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Carlumab
Carlumab from MedChemExpress
Be the first to write a review!
Citations:
(3)
Supplier Page
Supplier Page from
MedChemExpress for
Carlumab
Bulk Request
Description
Carlumab (CNTO 888) is a human anti-
CCL2
(
chemokine ligand 2
) antibody with high affinity. Carlumab can be used in cancer research, particularly in prostate cancer
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Carlumab
Company
MedChemExpress
Price
$260.00
Supplier Page
View Company Product Page
Catalog Number
HY-P99188
Applications
Bioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Research Area
Cancer
Type
Chemical
Quantity
1 mg
Molecule Name
Carlumab
Add to Compare List
MedChemExpress
1 Deer Park Drive, Suite F
MONMOUTH JUNCTION
,
NJ
08852
United States
Phone
: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910
Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com
Company Profile
Website:
medchemexpress.com
Citations (3)
(1)
Mesenchymal Stem Cell‐Derived Extracellular Vesicles Modulate the Course of Peritoneal Inflammation Through Metabolic and Epigenetic Regulation
Advanced Science
January 1, 2026
Qiang Huang, Yuxiang Sun, Pengpeng Kuang, Juan Sun, Dandan Guo, Long Peng, Hu Zhou, Qinrong Song, Zhihao Huo, Canming Li,
et al.
one of the following conditions: CG, CG + MSC‐EVs, CG + anti‐IgG, or CG + anti‐CCL2 antibody (
MCE
,
HY‐P99188
).
After treatment
, the medium in the lower chamber was replaced with fresh complete
M199
medium, while
(2)
Targeting STING to disrupt macrophage-mediated adhesion in encapsulating peritoneal sclerosis
Commun Biol
August 23, 2025
Juan Sun, Yuxiang Sun, Dandan Guo, Huolin Ye, Qiang Huang, Hu Zhou, Canming Li, Mei Liao, Yujia You, Hongli Shang,
et al.
SHS + LPS, with a working concentration of 2 μM. And for anti-CCL2 treatment, 30 ug/mL of
Carlumab
(
HY-P99188
,
MCE
) or anti-IgG was added to mesothelial cells 30 min in advance.
Western blot
Cell extracts were
(3)
Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data
Journal of clinical pharmacology
October 1, 2013
Fetterly GJ, Aras U, Meholick PD, Takimoto C, Seetharam S, McIntosh T, de Bono JS, Sandhu SK, Tolcher A, Davis HM,
et al
.
<<
<
>
>>
Reviews
Be the First to Write a Review!
Carlumab from MedChemExpress
Supplier Page
View Company Product Page
$260.00
Product Specs
Company Info
Citations
Reviews
Back To Top